Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteins | 5 | 2012 | 474 | 1.090 |
Why?
|
| Insulin | 8 | 2012 | 619 | 1.020 |
Why?
|
| Cystine | 1 | 2012 | 20 | 0.410 |
Why?
|
| Amino Acid Sequence | 10 | 2012 | 1083 | 0.400 |
Why?
|
| Molecular Sequence Data | 7 | 2012 | 1447 | 0.370 |
Why?
|
| Cross-Linking Reagents | 2 | 2008 | 80 | 0.310 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2005 | 167 | 0.290 |
Why?
|
| Disulfides | 2 | 2002 | 40 | 0.250 |
Why?
|
| Circular Dichroism | 5 | 2005 | 99 | 0.220 |
Why?
|
| Protein Conformation | 4 | 2008 | 362 | 0.210 |
Why?
|
| Pregnancy Proteins | 1 | 2001 | 15 | 0.190 |
Why?
|
| Growth Substances | 1 | 2001 | 77 | 0.190 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2001 | 146 | 0.180 |
Why?
|
| Relaxin | 3 | 2005 | 30 | 0.170 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2005 | 381 | 0.160 |
Why?
|
| Neuropeptides | 1 | 1999 | 106 | 0.160 |
Why?
|
| Amino Acid Substitution | 2 | 2008 | 137 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2002 | 231 | 0.140 |
Why?
|
| Benzyl Compounds | 1 | 2015 | 2 | 0.130 |
Why?
|
| Biosynthetic Pathways | 1 | 2015 | 15 | 0.130 |
Why?
|
| Fungi | 1 | 2015 | 27 | 0.130 |
Why?
|
| Antifungal Agents | 1 | 2015 | 108 | 0.120 |
Why?
|
| Cyclic AMP | 2 | 2005 | 223 | 0.120 |
Why?
|
| Protein Binding | 2 | 2008 | 1027 | 0.120 |
Why?
|
| Peptides | 4 | 2005 | 455 | 0.110 |
Why?
|
| Cysteine | 2 | 2005 | 112 | 0.110 |
Why?
|
| DNA, Complementary | 2 | 2005 | 251 | 0.110 |
Why?
|
| Sphingolipids | 1 | 2015 | 337 | 0.100 |
Why?
|
| Amides | 1 | 2012 | 86 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 1745 | 0.090 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2005 | 306 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2012 | 2689 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2002 | 248 | 0.080 |
Why?
|
| Protein Folding | 1 | 2008 | 82 | 0.080 |
Why?
|
| Solutions | 1 | 2008 | 115 | 0.080 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2008 | 85 | 0.080 |
Why?
|
| Protein Structure, Secondary | 1 | 2008 | 136 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2008 | 99 | 0.080 |
Why?
|
| Receptors, Peptide | 2 | 2005 | 32 | 0.080 |
Why?
|
| Cell Line | 2 | 2015 | 1752 | 0.070 |
Why?
|
| Decidua | 1 | 2005 | 8 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2005 | 165 | 0.060 |
Why?
|
| Mice | 3 | 2015 | 8474 | 0.060 |
Why?
|
| Animals | 6 | 2015 | 20881 | 0.060 |
Why?
|
| COS Cells | 1 | 2004 | 155 | 0.060 |
Why?
|
| Uterus | 1 | 2004 | 77 | 0.060 |
Why?
|
| Tryptophan | 1 | 2004 | 65 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 322 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2004 | 112 | 0.060 |
Why?
|
| Lysine | 1 | 2004 | 96 | 0.060 |
Why?
|
| Premature Birth | 1 | 2005 | 150 | 0.050 |
Why?
|
| Swine | 3 | 1999 | 672 | 0.050 |
Why?
|
| Transfection | 1 | 2004 | 782 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2004 | 546 | 0.050 |
Why?
|
| Sequence Analysis | 1 | 2002 | 12 | 0.050 |
Why?
|
| Testis | 1 | 2002 | 37 | 0.050 |
Why?
|
| Radioimmunoassay | 1 | 2002 | 164 | 0.050 |
Why?
|
| Humans | 6 | 2012 | 68618 | 0.050 |
Why?
|
| Trypsin | 1 | 2002 | 64 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 272 | 0.050 |
Why?
|
| Isomerism | 1 | 2001 | 63 | 0.050 |
Why?
|
| Cattle | 1 | 2002 | 475 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2001 | 130 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1999 | 79 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2002 | 483 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 1999 | 420 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1999 | 346 | 0.040 |
Why?
|
| Microbial Viability | 1 | 2015 | 27 | 0.030 |
Why?
|
| Candidiasis | 1 | 2015 | 39 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 127 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 2015 | 77 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 137 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 260 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 226 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 397 | 0.030 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 148 | 0.030 |
Why?
|
| Female | 3 | 2005 | 38074 | 0.030 |
Why?
|
| Time Factors | 1 | 2001 | 4655 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 901 | 0.030 |
Why?
|
| Macrophages | 1 | 2015 | 647 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2550 | 0.020 |
Why?
|
| Extraembryonic Membranes | 1 | 2005 | 10 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1985 | 73 | 0.020 |
Why?
|
| Amino Acids | 1 | 1985 | 131 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 7029 | 0.010 |
Why?
|
| Somatomedins | 1 | 1982 | 16 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 1981 | 29 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2005 | 617 | 0.010 |
Why?
|
| Cytokines | 1 | 2005 | 866 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2005 | 1174 | 0.010 |
Why?
|
| Epitopes | 1 | 1981 | 146 | 0.010 |
Why?
|
| Male | 1 | 2002 | 37321 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1982 | 122 | 0.000 |
Why?
|
| Protein Multimerization | 1 | 1982 | 71 | 0.000 |
Why?
|
| Dinitrobenzenes | 1 | 1981 | 6 | 0.000 |
Why?
|
| Binding Sites, Antibody | 1 | 1981 | 34 | 0.000 |
Why?
|
| Ovalbumin | 1 | 1981 | 33 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1981 | 124 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1981 | 397 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1981 | 329 | 0.000 |
Why?
|
| DNA | 1 | 1981 | 597 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1981 | 597 | 0.000 |
Why?
|